Cancer Antigen 19-9; CA 199; CA199
Back to Test Catalogue
CA 19-9, Serum
Test ID: CA199
Test
Aliases/Synonyms
Method
Electrochemilumiscent Immunoassay
Report Includes
CA 19-9
Specimens
Serum
Clinical Utility
CA 19-9 is not specific for pancreatic cancer.
Test Location
Sunnybrook Health Sciences, 2075 Bayview Avenue, Toronto ON M4N 3M5
Test Version
30-Sep-2019
Specimen
Specimens
Serum
Sample Volume
1 mL
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 30 days |
| Frozen | 3 months |
Test Version
30-Sep-2019
Performance / Interpretation
Method
Electrochemilumiscent Immunoassay
Turnaround Time
3 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| CA 19-9 | kU/L |
|
||
|
Results must be interpreted in light of other clinical findings
|
||||
Test Location
Sunnybrook Health Sciences, 2075 Bayview Avenue, Toronto ON M4N 3M5
Test Version
30-Sep-2019
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| CA199 | 20851CA19-9 | kU/L |
Test Version
30-Sep-2019